FOXO1 and diabetes mellitus: The discrepancy between the in vivo and in vitro models in relation to the effect of FOXO1 on PP2A could be the presence of excess lipids brought in by the FOXO1–CD36 pathway observed with diabetes, which turns on PP2A, thereby activating BAD stimulated apoptotic process.